Rainer Zimmermann

Actelion

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers

108

PubMed author-name match

Trials

Studies that name Rainer Zimmermann as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:43 UTC. Open this list on ClinicalTrials.gov

Ph2
NCT03942211 · A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag
Actelion · terminated · Sarcoidosis-associated Pulmonary Hypertension · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 04:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:43 UTC. The ranking covers the 200 most relevant of 108 PubMed records, and a shared surname and initials can bring in a namesake. All 108 on PubMed

Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise.
Circulation · 1997
258 citations
RCR 7.5
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
J Clin Oncol · 1994
209 citations
RCR 7.2
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
J Am Coll Cardiol · 2013
161 citations
RCR 5.2
Sinus floor augmentation with beta-tricalciumphosphate (beta-TCP): does platelet-rich plasma promote its osseous integration and degradation?
Clin Oral Implants Res · 2003
149 citations
RCR 6.6
Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study.
Eur Urol · 2009
126 citations
RCR 5.4
Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
Laryngoscope · 2009
119 citations
RCR 5.3
Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study.
Blood · 2004
117 citations
RCR 3.5
Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients.
Thromb Res · 1990
110 citations
RCR 4.5
Cortical correlates of false expectations during pain intensity judgments--a possible manifestation of placebo/nocebo cognitions.
Brain Behav Immun · 2005
91 citations
RCR 2.6
Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
Arch Gen Psychiatry · 1994
90 citations
RCR 3.5